Searched for
PEPTIDE SYNTHESIS
Can Granules India leverage its strong product pipeline to offset recent profit declines?Granules India's stock shows a slight recovery despite reporting lower profits in the June quarter. Investors are positive about the compan...22 Aug, 2025, 06.30 AM IST- Anthem Biosciences sets IPO price band at Rs 540-570/shareAnthem Biosciences is launching its IPO from July 14-16. The price is fixed between Rs 540 to Rs 570. The IPO aims to raise Rs 3,395 crore ...09 Jul, 2025, 05.26 PM IST
- Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14Anthem Biosciences' Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CR...08 Jul, 2025, 05.37 PM IST
- Granules India shares in focus on acquiring Swiss firm for Rs 192 crGranules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The ...24 Feb, 2025, 08.27 AM IST
- Granules acquires Swiss firm for Rs 192 cr; forays into CDMO spaceGranules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acqu...21 Feb, 2025, 10.52 PM IST
- Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?Divi's Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral ...04 Feb, 2025, 11.17 AM IST
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...31 Dec, 2024, 05.54 PM IST
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters and investors....31 Dec, 2024, 05.43 PM IST
- Divi’s Laboratories Q2 Results: Company posts 47% jump in net profit in Q2FY25Divi's Laboratories witnessed a 46.6% surge in profit, reaching Rs. 510 crores in Q2FY25, fueled by robust growth in their custom synthesis...10 Nov, 2024, 09.14 AM IST
- US co Amneal plans units in India for weight-loss drugsAmneal Pharmaceuticals is set to invest $150-200 million over four to five years to build a manufacturing facility in Ahmedabad for weight ...09 Oct, 2024, 12.13 AM IST
- Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 new plantsAmneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...08 Oct, 2024, 06.53 PM IST
- Stock to watch: Shilpa Medicare stock in focus after receiving CEP from EDQM for diabetes drugShares of Shilpa Medicare will be highlighted as its subsidiary, Shilpa Pharma Lifesciences, obtained a certificate of suitability from Eur...04 Oct, 2024, 09.13 AM IST
- Motilal Oswal Financial Services neutral on Divi's Laboratories, target price-Rs 2620Promoters held 51.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 15.15 per cent, DIIs 20.5 per cent.20 Mar, 2023, 11.23 AM IST
- Ingredients of life found around stars 400 light-years awayAstronomers harnessed the power of the Atacama Large Millimetre/submillimetre Array (ALMA) in Chile to detect the prebiotic complex organic...09 Jun, 2017, 02.29 PM IST
- Life enabling chemical found around infant starsLondon, June 9 (IANS) Astronomers have detected a life enabling organic compound -- methyl isocyanate -- around an infant star system some ...09 Jun, 2017, 02.09 PM IST
- Drugs for Ebola likely to have an Indian connectionIndia may well be the place where the drug to fight the killer Ebola virus originates, with two drug candidates discovered in Bengaluru.20 Dec, 2014, 01.03 PM IST
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...24 Jan, 2011, 06.30 AM IST
Load More
